menu search

This analyst thinks 89bio's pegozafermin data has exceeded expectations

In June, 89bio Inc (NASDAQ: ETNB) announced topline results from the ENTRIGUE Phase 2 proof-of-concept study of pegozafermin for...

July 11, 2022, 2:24 pm

Celldex (cldx) down on interim data from phase ib study in csu

Celldex (CLDX) posts interim data from the phase Ib study evaluating barzolvolimab in patients with moderate to...

July 4, 2022, 1:12 pm

7 growth stocks to buy in july 2022

The severe macroeconomic climate has led investors toward defensive plays, creating buy opportunities i...

July 4, 2022, 9:29 am

Pulmonx: interesting technology but struggling with adoption

FDA approved technology to treat severe emphysema. Sizeable $12 billion market opportunity....

July 2, 2022, 3:04 am

China's stimulative policy actions: turning the tide for investors

China's zero-COVID policy has cratered the economy, severely hampering mobility and discouraging consum...

July 1, 2022, 11:05 am

Inflarx provides development update for vilobelimab in skin disorder, covid-19

InflaRx N.V. (NASDAQ: IFRX) provided a development update for its monoclonal anti-C5a antibody, vilobelimab, in pyoderma gangrenosum (PG) and...

June 29, 2022, 12:09 pm

Why trevi therapeutics shares trading higher today?

Trevi Therapeutics Inc (NASDAQ: TRVI) has announced positive results from its Phase 2b/3 PRISM trial of Haduvio in treating prurigo nodularis, a ch...

June 29, 2022, 8:44 am

Can-fite biopharma shares jump after piclidenoson data in psoriasis trial

Can-Fite BioPharma Ltd (NYSE: CANF) announced topline results from the COMFORT Phase 3 trial of Piclidenoson in more than 400 adults with moderate ...

June 29, 2022, 7:57 am

89bio posts promising pegozafermin data for severe hypertriglyceridemia

89bio Inc (NASDAQ: ETNB) announced topline results from the ENTRIGUE Phase 2 proof-of-concept study of pegozafermin for...

June 29, 2022, 6:07 am

The cheesecake factory: have the cake and eat it

The Cheesecake Factory is attractive on many levels. It trades far below its past valuation and figures are still recovering. The share price is too...

June 28, 2022, 6:52 pm

Google's shares are severely underpriced

We remain big fans of Alphabet's shares and value them at $3,146 each. The company is a net cash-rich, free cash flow-generating, secular-growing powe...

June 27, 2022, 12:39 am

Here's how 5 warren buffett stocks would perform in a severe recession

Buffett owns a lot of bank stocks, which are staring at a possible recession....

June 26, 2022, 6:15 am

Banks passing fed's stress test should benefit this etf

The largest U.S. banks passed the Federal Reserve Board's annual stress test with flying colors, showing that they have enough capital to continue len...

June 24, 2022, 3:47 pm

U.s. fed says banks can weather severe downturn comfortably

The largest U.S. banks would remain well capitalized in the event of a severe economic shock, the U.S. ...

June 23, 2022, 4:32 pm

Xme benefits from severe commodity supply shortages

In this article, I discuss one of the most important macro risks and opportunities on the market as we're facing...

June 21, 2022, 4:42 pm

Long byd, short tesla - a great tactical pair trade

Tesla stock is still extremely expensive, despite having been beaten down severely in the ongoing marke...

June 20, 2022, 3:13 pm

Abbott pauses baby formula production in michigan after heavy rains

(Reuters) -Abbott Laboratories said on Wednesday it has stopped production of its EleCare specialty formula after...

June 16, 2022, 12:07 am

Today in crypto: bitcoin etfs decline up to 70%; forum questions blockchain's usefulness

Cryptocurrency exchange-traded funds (ETFs) that track Bitcoin through managed future contracts were trading all-time lows Wednesday (June 15) in the ...

June 15, 2022, 6:52 pm

Packaging corporation of america: expect performance to remain strong

Packaging Corporation of America has held up surprisingly well during this recent severe market downtur...

June 15, 2022, 4:16 pm

Concert pharmaceuticals: a balanced risk/reward

Concert Pharmaceuticals has a JAK inhibitor for alopecia areata (AA) that may be superior to competitive products. The company cites a figure of 1.5m ...

June 15, 2022, 11:48 am


Search within

Pages Search Results: